• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

DWWD:GR

185.0890 EUR 1.5590 0.85%

As of 13:48:09 ET on 12/19/2014.

Snapshot for DWS Biotech (DWWD)

Open: 185.5000 High - Low: 187.8900 - 179.0100 Primary Exchange: Frankfurt
Volume: 2,433 52-Week Range: 104.8100 - 187.8900 Beta vs NBI: 1.0011

ETF Chart for DWWD

No chart data available.
  • DWWD:GR 185.0890
  • 1D
  • 1M
  • 1Y
183.5300
Interactive DWWD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DWWD

DWS Biotech is an open-end fund incorporated in Germany. The Fund's objective is capital growth. The Fund invests primarily in biotech equities worldwide. The Fund focuses on companies in the U.S. and the portfolio may also include selected pharmaceutical and medical equipment firms. The Fund's investment is oriented on the MSCI BioTecnology Select Index.

Inception Date: 1999-08-16 Telephone: Tel. 49-1803-10111011
Managers: NOUSHIN IRANI TURNER / HOLGER GEISSLER
Web Site: www.dws.de

Fundamentals for DWWD

NAV (on 2014-12-19) 185.9600
Assets (M) (on 2014-12-19) 400.6905
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -0.47
Average 52-Week % Premium -0.6160
Fund Leveraged N

Dividends for DWWD

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-10-01) 0.0237
Dividend Yield (ttm) 0.02%

Performance for DWWD

1-Month +9.51% 1-Year +63.03%
3-Month +21.46% 3-Year +47.54%
Year To Date +60.53% 5-Year +34.30%
Expense Ratio 1.70

Top Fund Holdings for DWWD

Filing Date: 09/30/2014
Name Position Value % of Total
Gilead Sciences Inc 376,000 31,865,110 9.838%
Celgene Corp 415,000 31,287,177 9.660%
Biogen Idec Inc 97,578 25,395,402 7.841%
Vertex Pharmaceuticals Inc 208,050 18,679,711 5.767%
Alexion Pharmaceuticals Inc 132,180 17,499,453 5.403%
Amgen Inc 119,210 13,162,444 4.064%
Illumina Inc 100,137 13,041,751 4.027%
BioMarin Pharmaceutical Inc 225,000 12,947,446 3.997%
Regeneron Pharmaceuticals Inc 44,823 12,541,776 3.872%
Salix Pharmaceuticals Ltd 76,295 9,368,854 2.893%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil